Assessment of the Clinical Management of Fragility Fractures and Implications for the New HEDIS Osteoporosis Measure

Keywords

Medicine

References

• Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. A comparison of two centres in the United Kingdom.Ann Murray, Conor McQuillan, Brian Kennon — 2005
• Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in QuebecAlain Vanasse, Pierre Dagenais, Theo Niyonsenga — 2005
• Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment.Adrianne C. Feldstein, Gregory A. Nichols, Patricia J. Elmer — 2003
• Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*†Kevin B. Freedman, Frederick S. Kaplan, Warren B. Bilker — 2000
• Health care utilization and expenditures in the United States: a study of osteoporosis-related fracturesLucinda Orsini, Matthew D. Rousculp, Stacey R. Long — 2005
• A Chronic Disease Score with Empirically Derived WeightsDaniel O. Clark, Michael Von Korff, Kathleen Saunders — 1995
• Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical SynthesisCarolyn M. Klotzbuecher, Philip D. Ross, Pamela B. Landsman — 2000
• Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationNancy Ray, Julien K. Chan, Mae Thamer — 1997
• Burden of osteoporosis and fracturesRichard Keen — 2003
• Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons.Christine Simonelli, Kathleen Killeen, Susan Mehle — 2002
• Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic reviewVictoria Elliot‐Gibson, Earl R. Bogoch, S. A. Jamal — 2004
• Evaluation and management of osteoporosis following hospitalization for low-impact fractureChristine Simonelli, Ya-Ting Chen, Julie Morancey — 2007
• Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions.Daniel H. Solomon, Charles A. Morris, Hailu Cheng — 2005
• Missed opportunities for prevention of osteoporotic fracture.Teresa C. Gallagher, Olga Geling, Florence Comite — 2002
• Improvement in the Undertreatment of Osteoporosis Following Hip FractureAtul B. Joshi, Ljubisa Markovic, Kevin Hardinge — 2002
• Barriers and solutions to osteoporosis care in patients with a hip fracture.John D. Kaufman, Mark E. Bolander, Andrew D. Bunta — 2003
• Managing osteoporosis in a managed care population.Diana Brixner — 2006

Cited by

• A lymphoid enhancer binding factor (Lef) 1 isoform regulates osteoblast maturation.Luke H. Hoeppner — 2010
• Bone mineral density testing after fragility fracture: Informative test results likely.Joshua Posen, Dorcas Beaton, Joanna E. M. Sale — 2013
• More bone density testing is needed, not lessE. Michael Lewiecki, Andrew J. Laster, Paul D. Miller — 2012
• Sclerostin and skeletal healthMaryam Sharifi, Lisa Ereifej, E. Michael Lewiecki — 2015
• Denosumab: a novel biological therapy for osteoporosisDavid R.P. Guay — 2011
• Prevention, Screening, and Management of Osteoporosis: An Overview of the Current StrategiesFrank Bonura — 2009
• 2008 Santa Fe Bone Symposium: update on osteoporosis.E. Michael Lewiecki, Sanford Baim, John P. Bilezikian — 2009
• Association between teriparatide adherence and healthcare utilization and costs among hip fracture patients in the United States.Yang Zhao, Stephen S. Johnston, David M. Smith — 2014
• Adverse Drug InteractionsRyan Mayhew, June M. McKoy, Thanh Ha Luu — 2010
• Denosumab for the Treatment of Osteoporosis and Cancer‐Related ConditionsE. Michael Lewiecki, John P. Bilezikian — 2012
• Treatment of osteoporosis with denosumab.E. Michael Lewiecki — 2010
• The Role of Risk Communication in the Care of OsteoporosisE. Michael Lewiecki — 2011
• Fighting the Fracture Cascade: Evaluation and Management of Osteoporotic FracturesFleur Sack — 2008
• Managing osteoporosis: Challenges and strategiesE. Michael Lewiecki — 2009
• Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosisE. Michael Lewiecki — 2011
• Emerging drugs for postmenopausal osteoporosisE. Michael Lewiecki — 2009
• Risk for Fractures with Centrally Acting Muscle Relaxants: An Analysis of a National Medicare Advantage Claims DatabaseAdam G. Golden, Qianli Ma, Vinit Nair — 2010
• Denosumab for the Management of Postmenopausal OsteoporosisAndrea Singer, Andreas Grauer — 2010
• Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patientsJoanna E. M. Sale, Dorcas Beaton, Joshua Posen — 2011
• Established Osteoporosis and Gaps in the Management: Review from a Teaching hospitalWI Al-Bakr, Al-Omran As, AA Al-Othman — 2014

Related papers

No related papers recorded.